Benefits of Statins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitors for Patients with Peripheral Arterial Disease.

Kosmas I ParaskevasDebabrata MukherjeeTheofanis T Papas
Published in: Current vascular pharmacology (2023)